March 2, 2021 Edition COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can findthe latest public health information from CDC at www.coronavirus.govand the latest research information from NIH athttps://www.covid19.nih.gov . Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. |
|
| People with SARS-CoV-2 antibodies, a sign of prior infection, were much less likely to test positive for COVID-19 in the following months. |
|
| Researchers found that fine particulate matter levels in the air of subway systems across the Northeastern U.S exceed air safety standards. |
|
| A combination of two monoclonal antibodies prevented and effectively treated Middle East Respiratory Syndrome (MERS) in mice. |
|
|
